Castle Biosciences's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Castle Biosciences (NASDAQ:CSTL) is set to release its latest quarterly earnings report on August 2, 2023. Analysts estimate an earnings per share (EPS) of $-1.01. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $16.85, down 44.77% over the last 52-week period.
August 04, 2023 | 9:50 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Castle Biosciences is expected to report an EPS of $-1.01. The company's history of missing EPS estimates and subsequent share price drops could potentially impact the stock negatively.
Castle Biosciences has a history of missing EPS estimates, which has typically resulted in a drop in share price. Given this trend and the current analyst estimate of an EPS of $-1.01, there is a potential for a negative impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100